PMV Pharmaceuticals Total Liabilities

PMV Pharmaceuticals (PMVP) currently reports a total liabilities of $11M as of June 2026. That compares with $12M in the prior-year period — down 13.7% year over year. Use the charts on this page to explore PMV Pharmaceuticals's total liabilities history and peer comparisons.

PMV Pharmaceuticals's total liabilities decreased from $12M to $11M — a 13.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PMV Pharmaceuticals reported $11M in total liabilities as of June 2026. That compares with $12M in the prior-year period — down 13.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for PMV Pharmaceuticals, and consider following PMVP for alerts when major investors trade the stock.

PMV Pharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PMVP with unrelated industries.